These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34224787)

  • 1. Liposome composition in drug delivery design, synthesis, characterization, and clinical application.
    Large DE; Abdelmessih RG; Fink EA; Auguste DT
    Adv Drug Deliv Rev; 2021 Sep; 176():113851. PubMed ID: 34224787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant Effects on Lipid-Based Vesicles Properties.
    Bnyan R; Khan I; Ehtezazi T; Saleem I; Gordon S; O'Neill F; Roberts M
    J Pharm Sci; 2018 May; 107(5):1237-1246. PubMed ID: 29336980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery.
    Paliwal SR; Paliwal R; Vyas SP
    Drug Deliv; 2015 May; 22(3):231-42. PubMed ID: 24524308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
    Almeida B; Nag OK; Rogers KE; Delehanty JB
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compositional inhomogeneity of drug delivery liposomes quantified at the single liposome level.
    Andresen TL; Larsen JB
    Acta Biomater; 2020 Dec; 118():207-214. PubMed ID: 33065286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer lipids for drug delivery: from heads to tails.
    Kohli AG; Kierstead PH; Venditto VJ; Walsh CL; Szoka FC
    J Control Release; 2014 Sep; 190():274-87. PubMed ID: 24816069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-ligand conjugates: a review on the current state of art.
    Eroğlu İ; İbrahim M
    J Drug Target; 2020 Mar; 28(3):225-244. PubMed ID: 31339374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes as biocompatible and smart delivery systems - the current state.
    Dymek M; Sikora E
    Adv Colloid Interface Sci; 2022 Nov; 309():102757. PubMed ID: 36152374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects.
    Tahara K; Tomida H; Ito Y; Tachikawa S; Onodera R; Tanaka H; Tozuka Y; Takeuchi H
    Int J Pharm; 2016 May; 505(1-2):139-46. PubMed ID: 27012982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
    Müllertz A; Ogbonna A; Ren S; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of mono- and multi-hydroxyl low toxicity pH-sensitive cationic lipids for drug delivery.
    Zhao Z; Yao W; Wang N; Liu C; Zhou H; Chen H; Qiao W
    Eur J Pharm Sci; 2019 May; 133():69-78. PubMed ID: 30914360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
    Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
    Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.
    Abri Aghdam M; Bagheri R; Mosafer J; Baradaran B; Hashemzaei M; Baghbanzadeh A; de la Guardia M; Mokhtarzadeh A
    J Control Release; 2019 Dec; 315():1-22. PubMed ID: 31647978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.